Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

See all formats and pricing


Select Volume and Issue
Loading journal volume and issue information...

Biomarkers for early detection of mesothelioma in asbestos-exposed subjects

Eun-Kee Park1 / Paul S. Thomas2 / Deborah H. Yates1

1Department of Thoracic Medicine, St Vincent's Hospital, NSW, Australia

2Faculty of Medicine, School of Medical Sciences, University of New South Wales, NSW, Australia

Corresponding author: Deborah H. Yates, MD, Department of Thoracic Medicine, St Vincent's Hospital, Darlinghurst, Sydney NSW 2010, Australia Phone: +61-2-8382-2330, Fax: +61-2-8382-2505,

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 48, Issue 11, Pages 1673–1674, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2010.306, August 2010

Publication History

Published Online:

Keywords: asbestos-related diseases; biomarker; osteopontin; soluble mesothelin related protein

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Comments (0)

Please log in or register to comment.